Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INTERFERON ALFA-2B for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 22 adverse event reports in the FDA FAERS database where INTERFERON ALFA-2B was used for Neoplasm malignant.

Most Reported Side Effects for INTERFERON ALFA-2B

Side Effect Reports % Deaths Hosp.
Product use in unapproved indication 224 10.8% 20 18
Off label use 207 10.0% 8 27
Fatigue 206 9.9% 5 26
Nausea 120 5.8% 4 20
Influenza like illness 105 5.1% 0 8
Drug ineffective 94 4.5% 7 10
Product use issue 86 4.1% 10 5
Headache 80 3.9% 0 13
Pyrexia 80 3.9% 6 33
No adverse event 76 3.7% 0 0
Adverse event 65 3.1% 2 24
Malaise 62 3.0% 2 23
Death 60 2.9% 59 13
Diarrhoea 57 2.8% 3 11
Decreased appetite 55 2.7% 3 17

Other Indications for INTERFERON ALFA-2B

Malignant melanoma (190) Hepatitis c (137) Cutaneous t-cell lymphoma (83) Mycosis fungoides (81) Product used for unknown indication (79) Chronic hepatitis c (77) Bladder cancer (65) Covid-19 (43) Adult t-cell lymphoma/leukaemia (29) Chronic myeloid leukaemia (29)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

INTERFERON ALFA-2B Full Profile All Neoplasm malignant Drugs INTERFERON ALFA-2B Demographics INTERFERON ALFA-2B Timeline